Tag - Illumina

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

The Much Needed Narrative Behind Recent Female Representation Among Nobel Laureates

Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition

Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services

Enlightenbio Releases New Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle

Helix® Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform

NuProbe Closes $42M Fundraising

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

2020 Was Not Just About COVID-19

Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing

PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets

Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)

Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria

Copyright © 2026. enlighenbio LLC. All rights reserved.